Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Pham HN, Ibrahim R, Sainbayar E, Olson A, Singh A, Khanji MY, Lee J, Somers VK, Wenger C, Chahal CAA, Mamas MA. Burden of Hyperlipidemia, Cardiovascular Mortality, and COVID-19: A Retrospective-Cohort Analysis of US Data. J Am Heart Assoc. 2025 03 04; 14(5):e037381.
-
Nei M, Ho J, Ho RT. Cardiovascular Effects of Antiseizure Medications for Epilepsy. CNS Drugs. 2025 04; 39(4):383-401.
-
Doolub G, Raichman A, Abramov D, Bang V, Parwani P, Karunanithi K, Abdel-Qadir H, Kobo O, Mamas MA. Temporal trends in cardiovascular mortality among patients with hematological malignancies: a 20-year perspective. Expert Rev Cardiovasc Ther. 2025 Jan-Feb; 23(1-2):35-43.
-
Havranek B, Loh R, Torre B, Redfield R, Halegoua-DeMarzio D. Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes. Sci Rep. 2025 02 10; 15(1):4947.
-
Kobo O, Kaur G, Tamis-Holland JE, Zaman S, Bullock-Palmer RP, Tamirisa K, Gulati M, Mamas MA. Association of American Heart Association's Life's Essential 8 and mortality among US adults with and without cardiovascular disease. J Cardiol. 2025 Aug; 86(2):155-163.
-
Rajiah PS, Sundaram B, Ng MY, Ranganath P, Araoz PA, Bolen MA. Artifacts at Cardiac MRI: Imaging Appearances and Solutions. Radiographics. 2025 01; 45(1):e230200.
-
Alshahrani AA, Kontopantelis E, Morgan C, Ravindrarajah R, Martin GP, Mamas MA. Cardiovascular diseases in patients with cancer: A comprehensive review of epidemiological trends, cardiac complications, and prognostic implications. Chin Med J (Engl). 2025 Jan 20; 138(2):143-154.
-
Cipolletta E, Nakafero G, McCormick N, Yokose C, Avery AJ, Mamas MA, Choi HK, Tata LJ, Abhishek A. Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data. Lancet Rheumatol. 2025 Mar; 7(3):e197-e207.
-
Ho FK, Dale C, Mizani MA, Bolton T, Pearson ER, Valabhji J, Delles C, Welsh P, Nakada S, Mackay D, Pell JP, Tomlinson C, Petersen SE, Bray B, Ashworth M, Rahimi K, Mamas M, Halcox J, Sudlow C, Sofat R, Sattar N. Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study. PLoS Med. 2024 Nov; 21(11):e1004485.
-
Petriceks AH, Appel LJ, Miller ER, Mitchell CM, Schrack JA, Wanigatunga AA, Michos ED, Christenson RH, Rebuck H, Juraschek SP. Associations of Hypertension and Orthostatic Hypotension With Subclinical Cardiovascular Disease. J Gerontol A Biol Sci Med Sci. 2024 11 01; 79(11).